{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:04:33Z","timestamp":1787504673708,"version":"build-2736575974"},"reference-count":73,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,2]]},"DOI":"10.4269\/ajtmh.18-0805","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T03:00:42Z","timestamp":1603854042000},"page":"2174-2182","source":"Crossref","is-referenced-by-count":17,"title":["Antibody Correlates of Protection from Clinical Plasmodium falciparum Malaria in an Area of Low and Unstable Malaria Transmission"],"prefix":"10.4269","volume":"103","author":[{"given":"Karen E. S.","family":"Hamre","sequence":"first","affiliation":[{"name":"CDC Foundation, Atlanta, Georgia;"},{"name":"Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota;"},{"name":"Division of Global Pediatrics, University of Minnesota, Minneapolis, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartholomew N.","family":"Ondigo","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"},{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya;"},{"name":"Department of Biochemistry and Molecular Biology, Egerton University, Nakuru, Kenya;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Hodges","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetij","family":"Dutta","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute for Research, Silver Spring, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Theisen","sequence":"additional","affiliation":[{"name":"Statens Serum Institut, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Ayodo","sequence":"additional","affiliation":[{"name":"Jaramogi Oginga Odinga University of Science and Technology, Bondo, Kenya;"},{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandy C.","family":"John","sequence":"additional","affiliation":[{"name":"Division of Global Pediatrics, University of Minnesota, Minneapolis, Minnesota;"},{"name":"Department of Biochemistry and Molecular Biology, Egerton University, Nakuru, Kenya;"},{"name":"Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota;"},{"name":"Department of Pediatrics, Indiana University, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-3024.2006.00808.x","article-title":"Immune effector mechanisms in malaria","volume":"28","author":"Marsh","year":"2006","journal-title":"Parasite Immunol"},{"key":"b2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/CMR.00025-08","article-title":"Acquired immunity to malaria","volume":"22","author":"Doolan","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"b3","volume-title":"World Malaria Report 2016","year":"2016"},{"key":"b4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/192733a0","article-title":"Gamma-globulin and acquired immunity to human malaria","volume":"192","author":"Cohen","year":"1961","journal-title":"Nature"},{"key":"b5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4269\/ajtmh.1964.13.237","article-title":"The passive transfer of human malarial immunity","volume":"13","author":"McGregor","year":"1964","journal-title":"Am J Trop Med Hyg"},{"key":"b6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000441-197309000-00002","article-title":"Immunization of man against sporozite-induced falciparum malaria","volume":"266","author":"Clyde","year":"1973","journal-title":"Am J Med Sci"},{"key":"b7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4269\/ajtmh.1991.45.297","article-title":"Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria","volume":"45","author":"Sabchareon","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"b8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/223368a0","article-title":"Action of malarial antibody in vitro","volume":"223","author":"Cohen","year":"1969","journal-title":"Nature"},{"key":"b9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1473-3099(10)70262-0","article-title":"Efficacy of RTS,S\/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5\u201317 months in Kenya and Tanzania: a randomised controlled trial","volume":"11","author":"Olotu","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"b10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/icb.2009.27","article-title":"The future for blood-stage vaccines against malaria","volume":"87","author":"Richards","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"b11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(13)70005-7","article-title":"Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of Phase 2 data","volume":"13","author":"Bejon","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"b12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2217\/fmeb2013.13.144","article-title":"Correlates of protection for Plasmodium falciparum malaria vaccine development: current knowledge and future research","volume-title":"Malaria Vaccine Development: Over 40 Years of Trials and Tribulations: Future Medicine","author":"Beeson","year":"2014"},{"key":"b13","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3201\/eid1512.090627","article-title":"Possible interruption of malaria transmission, highland Kenya, 2007\u20132008","volume":"15","author":"John","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"b14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4269\/ajtmh.2012.11-0530","article-title":"Development of clinical immunity to malaria in highland areas of low and unstable transmission","volume":"87","author":"Rolfes","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"b15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1475-2875-13-163","article-title":"Sensitivity of fever for diagnosis of clinical malaria in a Kenyan area of unstable, low malaria transmission","volume":"13","author":"Mutanda","year":"2014","journal-title":"Malar J"},{"key":"b16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1475-2875-5-78","article-title":"Malaria hotspot areas in a highland Kenya site are consistent in epidemic and non-epidemic years and are associated with ecological factors","volume":"5","author":"Ernst","year":"2006","journal-title":"Malar J"},{"key":"b17","volume-title":"ArcGIS Desktop: Release 10","year":"2011"},{"key":"b18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/1475-2875-11-427","article-title":"Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens","volume":"11","author":"Ondigo","year":"2012","journal-title":"Malar J"},{"key":"b19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/infdis\/jiu225","article-title":"Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens","volume":"210","author":"Ondigo","year":"2014","journal-title":"J Infect Dis"},{"key":"b20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4269\/ajtmh.2005.73.222","article-title":"Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection","volume":"73","author":"John","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"b21","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1365-3156.2009.02370.x","article-title":"Environmental, socio-demographic and behavioural determinants of malaria risk in the western Kenyan highlands: a case-control study","volume":"14","author":"Ernst","year":"2009","journal-title":"Trop Med Int Health"},{"key":"b22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/9781118548387.ch4","article-title":"Model-building strategies and methods for logistic regression","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2013"},{"key":"b23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/9781118548387.ch7","article-title":"Logistic regression for matched case-control studies","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2013"},{"key":"b24","volume-title":"Stata Statistical Software: Release","year":"2011"},{"key":"b25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-5877(00)00115-X","article-title":"Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests","volume":"45","author":"Greiner","year":"2000","journal-title":"Prev Vet Med"},{"key":"b26","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1371\/journal.pmed.0020330","article-title":"Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa","volume":"2","author":"Barnes","year":"2005","journal-title":"PLoS Med"},{"key":"b27","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1371\/journal.pmed.0040309","article-title":"Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar","volume":"4","author":"Bhattarai","year":"2007","journal-title":"PLoS Med"},{"key":"b28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1475-2875-9-299","article-title":"Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects","volume":"9","author":"Steketee","year":"2010","journal-title":"Malar J"},{"key":"b29","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4269\/ajtmh.2006.74.972","article-title":"Reduction in infection with Plasmodium falciparum one year after the introduction of malaria control interventions on Bioko Island, Equatorial Guinea","volume":"74","author":"Kleinschmidt","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"b30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/526787","article-title":"Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children","volume":"197","author":"John","year":"2008","journal-title":"J Infect Dis"},{"key":"b31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0035-9203(00)90086-5","article-title":"Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria","volume":"94","author":"Migot-Nabias","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"b32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vaccine.2008.10.025","article-title":"Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan","volume":"27","author":"Iriemenam","year":"2009","journal-title":"Vaccine"},{"key":"b33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-3156.2007.01994.x","article-title":"Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?","volume":"13","author":"Nebie","year":"2008","journal-title":"Trop Med Int Health"},{"key":"b34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1475-2875-7-142","article-title":"Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children","volume":"7","author":"Dodoo","year":"2008","journal-title":"Malar J"},{"key":"b35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.0141-9838.2004.00705.x","article-title":"Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection","volume":"26","author":"Meraldi","year":"2004","journal-title":"Parasite Immunol"},{"key":"b36","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1086\/315341","article-title":"Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria","volume":"181","author":"Dodoo","year":"2000","journal-title":"J Infect Dis"},{"key":"b37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/IAI.61.1.103-108.1993","article-title":"Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children","volume":"61","author":"Dziegiel","year":"1993","journal-title":"Infect Immun"},{"key":"b38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/IAI.72.1.247-252.2004","article-title":"Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein","volume":"72","author":"Soe","year":"2004","journal-title":"Infect Immun"},{"key":"b39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/IAI.01147-07","article-title":"Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa","volume":"76","author":"Nebie","year":"2008","journal-title":"Infect Immun"},{"key":"b40","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1128\/IAI.69.9.5223-5229.2001","article-title":"Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity","volume":"69","author":"Theisen","year":"2001","journal-title":"Infect Immun"},{"key":"b41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4269\/ajtmh.1992.46.307","article-title":"Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia","volume":"46","author":"Hogh","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"b42","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/IAI.68.5.2617-2620.2000","article-title":"Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal","volume":"68","author":"Oeuvray","year":"2000","journal-title":"Infect Immun"},{"key":"b43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1475-2875-4-48","article-title":"Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission","volume":"4","author":"Lusingu","year":"2005","journal-title":"Malar J"},{"key":"b44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/infdis\/jir223","article-title":"Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic","volume":"204","author":"Greenhouse","year":"2011","journal-title":"J Infect Dis"},{"key":"b45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4269\/ajtmh.2002.66.7","article-title":"Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project","volume":"66","author":"Zhou","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"b46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4269\/ajtmh.1991.44.201","article-title":"Naturally acquired circumsporozoite antibodies and their role in protection in endemic falciparum and vivax malaria","volume":"44","author":"Wongsrichanalai","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"b47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JCM.26.5.923-927.1988","article-title":"Characterization of antibodies to sporozoites in Plasmodium falciparum malaria and correlation with protection","volume":"26","author":"Webster","year":"1988","journal-title":"J Clin Microbiol"},{"key":"b48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.3299709","article-title":"Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications","volume":"237","author":"Hoffman","year":"1987","journal-title":"Science"},{"key":"b49","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0035-9203(88)90495-6","article-title":"Anti-sporozoite antibodies and immunity to malaria in a rural Gambian population","volume":"82","author":"Marsh","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"b50","first-page":"359","article-title":"Circumsporozoite antibodies and falciparum malaria incidence in children living in a malaria endemic area","volume":"66","author":"Pang","year":"1988","journal-title":"Bull World Health Organ"},{"key":"b51","doi-asserted-by":"crossref","first-page":"e1000218","DOI":"10.1371\/journal.pmed.1000218","article-title":"The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: a systematic review and meta-analysis","volume":"7","author":"Fowkes","year":"2010","journal-title":"Plos Med"},{"key":"b52","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/INF.0b013e31822d1451","article-title":"Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria","volume":"30","author":"McCarra","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"b53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/509806","article-title":"Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection","volume":"195","author":"Polley","year":"2007","journal-title":"J Infect Dis"},{"key":"b54","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1373\/clinchem.2006.081695","article-title":"Profiling the antibody immune response against blood stage malaria vaccine candidates","volume":"53","author":"Gray","year":"2007","journal-title":"Clin Chem"},{"key":"b55","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1128\/IAI.68.10.5559-5566.2000","article-title":"Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum","volume":"68","author":"Okenu","year":"2000","journal-title":"Infect Immun"},{"key":"b56","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/IAI.01585-07","article-title":"Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria","volume":"76","author":"Osier","year":"2008","journal-title":"Infect Immun"},{"key":"b57","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/IAI.01129-08","article-title":"Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness","volume":"77","author":"Stanisic","year":"2009","journal-title":"Infect Immun"},{"key":"b58","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1086\/656413","article-title":"Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia","volume":"51","author":"Richards","year":"2010","journal-title":"Clin Infect Dis"},{"key":"b59","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4269\/ajtmh.1996.54.443","article-title":"Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity","volume":"54","author":"Al-Yaman","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"b60","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4269\/ajtmh.1999.61.488","article-title":"Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children","volume":"61","author":"Migot-Nabias","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"b61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-3024.2007.00951.x","article-title":"Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3","volume":"29","author":"Osier","year":"2007","journal-title":"Parasite Immunol"},{"key":"b62","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.vaccine.2004.05.031","article-title":"Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria","volume":"23","author":"Polley","year":"2004","journal-title":"Vaccine"},{"key":"b63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"b64","year":"2015"},{"key":"b65","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1207564","article-title":"Four-year efficacy of RTS,S\/AS01E and its interaction with malaria exposure","volume":"368","author":"Olotu","year":"2013","journal-title":"N Engl J Med"},{"key":"b66","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.vaccine.2005.01.142","article-title":"Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research","volume":"23","author":"Heppner","year":"2005","journal-title":"Vaccine"},{"key":"b67","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1016\/j.vaccine.2009.08.046","article-title":"Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-\u03b3\/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection","volume":"28","author":"Cummings","year":"2010","journal-title":"Vaccine"},{"key":"b68","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.vaccine.2006.06.081","article-title":"Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial","volume":"25","author":"Hermsen","year":"2007","journal-title":"Vaccine"},{"key":"b69","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1016\/j.vaccine.2010.07.085","article-title":"Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon","volume":"28","author":"Mordmuller","year":"2010","journal-title":"Vaccine"},{"key":"b70","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1016\/j.vaccine.2009.09.011","article-title":"Safety and immunogenicity of GMZ2\u2014a MSP3-GLURP fusion protein malaria vaccine candidate","volume":"27","author":"Esen","year":"2009","journal-title":"Vaccine"},{"key":"b71","doi-asserted-by":"crossref","first-page":"e22525","DOI":"10.1371\/journal.pone.0022525","article-title":"A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children","volume":"6","author":"Belard","year":"2011","journal-title":"PLoS One"},{"key":"b72","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/infdis\/jit185","article-title":"The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas","volume":"208","author":"Jepsen","year":"2013","journal-title":"J Infect Dis"},{"key":"b73","doi-asserted-by":"crossref","first-page":"P26","DOI":"10.1186\/1475-2875-9-S2-P26","article-title":"Design of a phase IIb, randomized, controlled, double-blind, multi-centre study to evalute the efficacy, safety, and immunogenicity of the GMZ2 candidate malaria vaccine in Ugandan, Ghanian, Burkinabe and Gabonese children aged 12\u201360 months","volume":"9","author":"Noor","year":"2010","journal-title":"Malar J"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T12:00:56Z","timestamp":1611748856000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajtmh.org\/doi\/10.4269\/ajtmh.18-0805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12,2]]}},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.18-0805","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,2]]}}}